Improving Upon Treatment Standards in HR+ Breast Cancer – Targeted Oncology
Posted: May 12, 2020 at 12:41 pm
Treatment of metastatic hormone receptor (HR)-positive, HER2-negative breast cancer is traditionally executed with the use of endocrine therapy. With the emergence of targeted therapies for the treatment of this disease, however, the landscape is rapidly shifting, and more therapies are under active research.
In the current landscape, oncologists have made room for CDK4/6 inhibition in combination with endocrine therapy, a combination that has been proven to improve upon progression-free and overall survival in this patient population.
At this point in time, we're grateful to have CDK4/6inhibition as our standard of care, but there is so much work going on and so many exciting new agents. What I what to think about is what lies ahead in the next decade in terms of the introduction of a lot of these newer agents into our clinics, Erica Mayer, MD, toldTargeted Oncology.
A new clinical trial is underway (PACE, NCT03147287) to further investigate CDK4/6 inhibition in combination with endocrine therapy after chemotherapy. In 3 arms of fulvestrant monotherapy, fulvestrant plus palbociclib, and fulvestrant plus palbociclib with avelumab (Bavencio), the study is primarily assessing progression-free survival (PFS), with overall response rate and treatment-emergent adverse events as secondary end points.
In an interview withTargeted Oncology, Mayer, senior medical oncologist, Breast Oncology Center, Dana-Farber Cancer Institute, discussed advances in the treatment landscape of HR-positive, HER2-negative breast, primarily with endocrine therapy and CDK4/6 inhibition.
TARGETED ONCOLOGY: Can you discuss advances in endocrine therapy in recent years and explain what you see for the future of endocrine therapy in advanced HR+, HER-negative breast cancer?
Mayer: Over the past several decades, we have primarily been using endocrine monotherapy to treat metastatic hormone receptor positive breast cancer. However, over the past several years weve had the introduction of new targeted therapies that we used in combination with an endocrine back bone, and the introduction of these agents has substantially improved progression free and overall survival for patients with metastatic hormone receptor positive HER2-negative disease. We had the introduction of the mTOR inhibitor everolimus, and the CDK4/6 inhibitors, palbociclib (Ibrance), ribociclib (Kisqali), and abemaciclib (Verzenio), as well as the most recent from 2019, a PI3 kinase inhibitor, alpelisib (Piqray).
At this point in time, there are at least 8 large randomized studies that have looked at the addition of a CDK4/6 inhibitor to back on endocrine therapy, either in the first- or second-line settings. There are trials that have used all 3 available agents and the diversity of endocrine back bone. Importantly and consistently, there is a substantial improvement in hazard ratio across the board of 0.5 to .055,which suggests a doubling and PFS with the addition of the CDK4/6 inhibitor, and that has become our standard of care for the majority of patients in the first-line or second-line settings.
In the past year, weve seen overall survival (OS) data from these agents and again, suggesting that there may be an OS advantage from the use CDK4/6 inhibitors and supporting the upfront use of these agents. The big question that has come up, though, is after a CDK4/6 inhibitor, if the cancer is progressing, what do we give next? What are our next best strategies? Should we be continuing on a CDK4/6 inhibitor like we would do with trastuzumab in HER2-positive breast cancer, or should we be switching to a different endocrine therapy with a new targeted partner? Also, how can we best select that targeted partner?
In terms of the idea of maintaining CDK4/6 inhibition, there are multiple studies ongoing trying to address this question. We are fortunate to lead a study called PACE, which is a randomized study open throughout the United States, in which patients who have progressed on a CDK4/6 inhibitor are then randomized to 1 of 3 arms, fulvestrant alone, which could be standard of care and many patients, fulvestrant with the CDK4/6 inhibitor, palbociclib, or a triplet combination of fulvestrant, palbociclib, and avelumab, which is an immunotherapy agent. This study is based off of some strong preclinical data and is actively accruing. Were hoping that will help address this question.
Beyond that, there has been research to understand mechanisms of resistance to CDK4/6 inhibitors and dissect that from known mechanisms of resistance to endocrine therapy. Ideally, we would love to think of a framework where we could, in real time, test the tumor or even test circulating tumor DNA to identify the mutation that is the cause of the resistance. Then we can apply a new targeted therapy with the next line of endocrine treatment to overcome that resistance. There are several candidates, therapies, and mechanisms which have been identified.
At this point in time, were grateful to have CDK4/6 inhibition as our standard of care, but there is so much work going on and so many exciting new agents. What I what to think about is what lies ahead in the next decade in terms of the introduction of a lot of these newer agents into our clinics.
TARGETED ONCOLOGY: With all the different agents that are available in the space, how do you determine which patients are eligible for which therapies?
Mayer: The paradigm of which treatment we give at which step in time has been something that's been changing a bit recently. As I mentioned, the first line of therapy that most patients will now be receiving would be in endocrine therapy with a CDK4/6 inhibitor, and I think it is important to note that in years past when patients showed evidence of what we think of as visceral disease, there may have been a tendency to start those patients with chemotherapy. Thats not necessary. We can give them endocrine therapy with a CDK4/6 inhibitor, which has a high response rate and a very favorable PFS and is much better tolerated than chemotherapy. This needs to be the standard of care for the vast majority of patients.
Following that, we're increasingly going to see the introduction of tumor genomics to help us identify mutations. We have 1 actionable mutation right now, which is a mutation in PIK3CA. For patients who have that mutation, the use of alpelisib may be an attractive way to go. However, for those who don't have a PIK3CA mutation, at this point in time, we have our standard endocrine therapies, and we also have everolimus. With ongoing trials were going to start to see some interesting new options for the other categories of mutations.
TARGETED ONCOLOGY: What is the key takeaway?
Mayer: The key takeaway is that none of these advances could have happened without laboratory discovery, translation to the clinic, and the completion of clinical trials. I think that for us to move as a field we need to help design the best possible trials. We need to support them all by structuring and running the trials. Importantly, all providers and patients need to work together to enter these trials and complete them and get answers these questions.
TARGETED ONCOLOGY: What accessible are some of these available agents?
Mayer: The majority of agents that I have discussed in the standard setting are FDA-approved.
These drugs that should be available to any patient, wherever they are in the United States. The availability outside the United States varies depending on each country's approval status.
Clinical trials are a challenge that our community needs to work on. Many clinical trials are available at the large academic medical centers and increasingly, trials could be open through our cooperative networks at community cancer centers or at satellite hospitals close to the larger centers. We still have many patients in this country who live very far away from institutions that have trials available for them, and I think we need to work harder to community oncologists and every breast cancer patient.
Visit link:
Improving Upon Treatment Standards in HR+ Breast Cancer - Targeted Oncology
- Hormone therapy: Is it right for you? - Mayo Clinic [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- LifeXmd :: Bioidentical Hormone Replacement Therapy Center [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Bioidentical hormones: Are they safer? - Mayo Clinic [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Diabetes and Hormone Center of the Pacific [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Hormone Replacement Clinic | Topeka & Lawrence KS [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Integrative Health and Hormone Clinic Cedar Rapids, IA [Last Updated On: May 31st, 2015] [Originally Added On: May 31st, 2015]
- Hormone Center - Home [Last Updated On: May 31st, 2015] [Originally Added On: May 31st, 2015]
- How Are Hormones And Anxiety Related? - Calm Clinic [Last Updated On: June 13th, 2015] [Originally Added On: June 13th, 2015]
- Women's Mood & Hormone Clinic / Moms Program | UCSF ... [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- Dallas Anti Aging Clinic for Men | Male Hormone ... [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- Hormone clinic to open - News Sentinel Story [Last Updated On: July 10th, 2015] [Originally Added On: July 10th, 2015]
- Male Hormone Replacement - Testosterone - The Turek Clinic [Last Updated On: August 1st, 2015] [Originally Added On: August 1st, 2015]
- Bio-Identical Hormones & Women's Services at Dr. Wright's ... [Last Updated On: August 21st, 2015] [Originally Added On: August 21st, 2015]
- HGH Therapy | HGH Clinics | Human Growth Hormone Therapy [Last Updated On: August 24th, 2015] [Originally Added On: August 24th, 2015]
- Long Island Hormone Therapy Clinic NY, Anti-Aging Clinics ... [Last Updated On: September 25th, 2015] [Originally Added On: September 25th, 2015]
- Home - Seattle Hormone Replacement Clinic for Men [Last Updated On: September 25th, 2015] [Originally Added On: September 25th, 2015]
- Medical Weight Loss Clinic of Utah - Hormone Replacement ... [Last Updated On: September 29th, 2015] [Originally Added On: September 29th, 2015]
- What are Hormones? - Hormone Replacement Therapy Denver [Last Updated On: October 4th, 2015] [Originally Added On: October 4th, 2015]
- Human growth hormone (HGH): Does it slow aging? - Mayo Clinic [Last Updated On: October 9th, 2015] [Originally Added On: October 9th, 2015]
- Bioidentical Hormone Replacement Therapy - Amen Clinics [Last Updated On: October 12th, 2015] [Originally Added On: October 12th, 2015]
- HD Medspa & Clinic | Lakeview Neighborhood, Chicago, for ... [Last Updated On: October 18th, 2015] [Originally Added On: October 18th, 2015]
- Denver Hormone Therapy | Denver Hormone Health [Last Updated On: April 8th, 2016] [Originally Added On: April 8th, 2016]
- Bioidentical Hormone Replacement Therapy for Men and Women ... [Last Updated On: April 29th, 2016] [Originally Added On: April 29th, 2016]
- The Endocrine Clinic | Singapore Hormone Specialists [Last Updated On: June 5th, 2016] [Originally Added On: June 5th, 2016]
- San Antonio Natural Hormone Therapy Clinic | Bio-Identical ... [Last Updated On: June 16th, 2016] [Originally Added On: June 16th, 2016]
- Does hormone replacement medication ... - Lindora Clinic [Last Updated On: June 30th, 2016] [Originally Added On: June 30th, 2016]
- FEMME CLINIQUE - Bio-Identical Hormone Therapy Clinic ... [Last Updated On: June 30th, 2016] [Originally Added On: June 30th, 2016]
- Dr Colin Holloway | Managing hormone imbalances [Last Updated On: July 2nd, 2016] [Originally Added On: July 2nd, 2016]
- melatonin hormone - University of Maryland Medical Center [Last Updated On: July 7th, 2016] [Originally Added On: July 7th, 2016]
- Human chorionic gonadotropin - Wikipedia, the free ... [Last Updated On: July 20th, 2016] [Originally Added On: July 20th, 2016]
- Talk to Nurse Rita - Health, Nursing & Clinic Matters [Last Updated On: July 24th, 2016] [Originally Added On: July 24th, 2016]
- NATESTO (testosterone) Nasal Gel CIII | Prescriber Site [Last Updated On: August 24th, 2016] [Originally Added On: August 24th, 2016]
- Home : Cleveland Clinic Journal of Medicine [Last Updated On: September 18th, 2016] [Originally Added On: September 18th, 2016]
- Ageing - Wikipedia, the free encyclopedia [Last Updated On: September 21st, 2016] [Originally Added On: September 21st, 2016]
- Melatonin - Wikipedia, the free encyclopedia [Last Updated On: September 24th, 2016] [Originally Added On: September 24th, 2016]
- Hormone Replacement Clinic in NJ | Healthy Aging Medical ... [Last Updated On: October 11th, 2016] [Originally Added On: October 11th, 2016]
- UT Southwestern, Dallas, Texas - UTSW Medicine (Patient ... [Last Updated On: October 15th, 2016] [Originally Added On: October 15th, 2016]
- Clinical Guidelines and Recommendations | Agency for ... [Last Updated On: November 15th, 2016] [Originally Added On: November 15th, 2016]
- Hormone Replacement Therapy | Born Clinic [Last Updated On: November 22nd, 2016] [Originally Added On: November 22nd, 2016]
- Medical Weight Loss | Endocrinology & Hormone Replacement [Last Updated On: November 25th, 2016] [Originally Added On: November 25th, 2016]
- West Coast Womens Clinic - Vancouver Womens Health Clinic [Last Updated On: November 28th, 2016] [Originally Added On: November 28th, 2016]
- Prolactin - Wikipedia [Last Updated On: December 11th, 2016] [Originally Added On: December 11th, 2016]
- Worrying about Anti Mullerian Hormones? | Baby Hopeful [Last Updated On: December 19th, 2016] [Originally Added On: December 19th, 2016]
- Risk of Pregnancy Loss in Subclinical Hypothyroidism - Endocrinology Advisor [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Public invited to women's clinic opening in New Albany - Evening News and Tribune [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Thyroid Hormone Therapy for Subclinical Hypothyroidism in Pregnancy - Medical News Bulletin [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Transgender youth in Alberta need more than 1 part-time clinic, says new campaign - CBC.ca [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- BRUCKNER: UNL a national model for trans, LGBT care - Daily Nebraskan [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- Hospital in Somerset becomes first in NJ to open LGBTQ health center - New Jersey 101.5 FM Radio [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- Four NIH-backed projects aim to advance the artificial pancreas - MobiHealthNews [Last Updated On: February 10th, 2017] [Originally Added On: February 10th, 2017]
- In Transition: Physical transitions can include hormone treatment, surgery - The Baylor Lariat [Last Updated On: February 10th, 2017] [Originally Added On: February 10th, 2017]
- Amphetamine use may 'speed up' heart aging - Medical News Today [Last Updated On: February 11th, 2017] [Originally Added On: February 11th, 2017]
- Nationwide Planned Parenthood protests energize patients, opponents - SFGate [Last Updated On: February 11th, 2017] [Originally Added On: February 11th, 2017]
- Women's wellness: Understanding hypothyroidism and pregnancy - The Killeen Daily Herald [Last Updated On: February 12th, 2017] [Originally Added On: February 12th, 2017]
- How This Police Officer Is Helping Trans Patients Get Better Care - Refinery29 [Last Updated On: February 13th, 2017] [Originally Added On: February 13th, 2017]
- Most cases of thyroid cancer are curable - Post-Bulletin [Last Updated On: February 13th, 2017] [Originally Added On: February 13th, 2017]
- Is hormone melatonin the link between sleep and breast cancer? - Knowridge Science Report [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- In West Africa, clinics confront suspicion, and husbands, one IUD at a time - STAT [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- 'Speed' and other recreational stimulants tied to heart damage - Fox News [Last Updated On: February 16th, 2017] [Originally Added On: February 16th, 2017]
- Research shows balancing hormones can aid weight loss - WLS-TV [Last Updated On: February 18th, 2017] [Originally Added On: February 18th, 2017]
- These transgender patients now have a place to change their lives all at once - Miami Herald [Last Updated On: February 20th, 2017] [Originally Added On: February 20th, 2017]
- Healthy eating, the Hyman way - Durham Herald Sun [Last Updated On: February 21st, 2017] [Originally Added On: February 21st, 2017]
- Balancing hormones and weight loss - UPMatters.com [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Have You Heard of These 5 Heart Attack Risk Factors? - Health Essentials from Cleveland Clinic (blog) [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Feeling stressed? Try these proven methods for chilling out - Los Angeles Times [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Mother & Son Swap Sexes At The Same Time! - Radar Online [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- The truth about why some men get sleepy after sex | Fox News - Fox News [Last Updated On: February 25th, 2017] [Originally Added On: February 25th, 2017]
- Wellness experts use hormone balancing to fight obesity - WNDU-TV [Last Updated On: February 25th, 2017] [Originally Added On: February 25th, 2017]
- These transgender patients now have a place to change their lives all at once - San Angelo Standard Times [Last Updated On: February 25th, 2017] [Originally Added On: February 25th, 2017]
- Obese couples may take longer to conceive - Fox News [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- Even More Reason to Kick That Sedentary Lifestyle - LifeZette [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- What Happens When Your Immune System Gets Stressed Out? - Health Essentials from Cleveland Clinic (blog) [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- Boutique Egg Freezing Clinics Are the Latest Trend for Those Looking to Delay Parenthood - Babble (blog) [Last Updated On: March 2nd, 2017] [Originally Added On: March 2nd, 2017]
- Municipal Hospital System Opens NYC's First Public Clinic Offering Gender-Reassignment Surgery - NY1 [Last Updated On: March 2nd, 2017] [Originally Added On: March 2nd, 2017]
- Walking has many Health Benefit - Plainview Daily Herald [Last Updated On: March 3rd, 2017] [Originally Added On: March 3rd, 2017]
- Isoflavones in food associated with reduced mortality for women with some breast cancers - Tufts Now [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Planned Parenthood New York Now Offers Transgender Hormone Replacement Therapy - The Mary Sue [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Doctor Allie International Hormone Success Doctor Joins the ... - Satellite PR News (press release) [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Hormone Therapy Clinic | Human Growth Hormone ... [Last Updated On: March 6th, 2017] [Originally Added On: March 6th, 2017]
- Dubai clinic offering free fertility tests for women throughout March ... - Emirates 24|7 [Last Updated On: March 8th, 2017] [Originally Added On: March 8th, 2017]